Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Shotwell

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Organic Letters|November 5, 2004
Pyridine-capped, oligomeric (o-phenyleneethynylene)sSandra Shotwell, Paul M Windscheif, Mark D Smith, et al.
Infectious Diseases and Therapy|February 20, 2022
Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial DecisionsStephen J Balevic, Shruti M Raja, Rachel Randell, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Organic Letters|November 5, 2004
Pyridine-capped, oligomeric (o-phenyleneethynylene)sSandra Shotwell, Paul M Windscheif, Mark D Smith, et al.
Infectious Diseases and Therapy|February 20, 2022
Adverse Reactions in a Phase 1 Trial of the Anti-Malarial DM1157: An Example of Pharmacokinetic Modeling and Simulation Guiding Clinical Trial DecisionsStephen J Balevic, Shruti M Raja, Rachel Randell, et al.
Pageof 1